| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 426.055 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 492.009 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 301.28 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 460.315 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 572.046 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 328.808 | 88 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 498.318 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 425.846 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 420.109 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 513.729 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 423.172 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 470.973 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 256.679 | 86 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 385.205 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 358.881 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 305.972 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 408.984 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 384.581 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 584.304 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 487.245 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 457.517 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 555.266 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 491.842 | 91 |